Althea Althea has said it is “on the verge” of becoming cash flow positive as it […]
Industry Roundup: Althea, Cann Group, Emyria, Neurotech, Bod Science, Elixinol, Creso Pharma, MGC Pharma
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Dr Thomas Duthy
Elixinol Wellness
Emyria
Health House International
Hemp Foods Australia
Joshua Fegan
MGC Pharmaceuticals
Michael Winlo
Neurotech International
The Sustainable Nutrition Group
William Lay
Related Articles
